# Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets

> **NCT03787927** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Bloodworks** · enrollment: 60 (estimated)

## Conditions studied

- Bleeding
- Platelet Dysfunction Due to Drugs
- Platelet Dysfunction

## Interventions

- **DRUG:** Autologous Platelet Transfusion (room-temperature-stored)
- **DRUG:** Autologous Platelet Transfusion (cold-stored 5 days)
- **DRUG:** Autologous Platelet Transfusion (cold-stored 10 days)
- **DRUG:** Autologous Platelet Transfusion (cold-stored 15 days)
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT03787927
- **Lead sponsor:** Bloodworks
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-03
- **Primary completion:** 2021-12-03
- **Final completion:** 2021-12-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03787927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03787927, "Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03787927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*